SEC Form 4 · accession 0001179110-17-008256
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Hirsch
Director
Period of report
May 30, 2017
Accepted (ET)
May 31, 2017 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001650664
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $13.75 | May 30, 2017 | A | 23,076 | A | — | May 29, 2027 | Common Stock | 23,076 | 23,076 | D |
Explanation of responses
- F1This option was granted on May 30, 2017 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on May 30, 2018 through May 30, 2020.